Sahin Ugur
Chief Executive Officer
Sahin Ugur has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Sep 11, 2026.
On the most recent filing, Sahin Ugur is listed as Chief Executive Officer at BioNTech SE. Inside the rolling window, Sahin Ugur reported no open-market purchases and 5 open-market sales totaling $17.1M in BNTX. The largest disclosed transaction in the window is a sale of 45,000 BNTX shares on Sep 3, 2026, worth $4.6M.
Companies traded
Other insiders at BNTX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$17.1M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Sahin Ugur made?
Sahin Ugur has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company since 2026.
Which companies does Sahin Ugur trade?
Sahin Ugur has filed SEC Form 4 disclosures for 1 company, including BNTX.
When was Sahin Ugur's most recent SEC Form 4 filing?
Sahin Ugur's most recent SEC Form 4 filing on Tracefour is dated Sep 11, 2026.
What is Sahin Ugur's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Sahin Ugur is listed as Chief Executive Officer.
What is Sahin Ugur's total buy and sell value in the current window?
Inside the rolling retention window, Sahin Ugur bought $0 and sold $17.1M based on SEC Form 4 filings.
What was Sahin Ugur's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 45,000 BNTX shares on 2026-09-03, worth $4.6M, per SEC Form 4 filings.